Is targeted therapy or immunotherapy better for gallbladder cancer?

Written by Liu Wu Cai
Hepatobiliary Surgery
Updated on November 17, 2024
00:00
00:00

The treatment of gallbladder cancer cannot be judged as whether targeted therapy or immunotherapy is better, but should be analyzed based on the specific condition of the disease.

For early-stage gallbladder cancer patients, if no metastasis has occurred, the best treatment at this time is primarily surgical removal. Early-stage surgical removal can achieve a cure, and regular postoperative ultrasound checks to monitor the disease progression are sufficient.

However, if the gallbladder cancer progresses to a late stage, there might be metastasis to other parts of the body, corresponding symptoms appear, and the disease progresses rapidly. The opportunity for surgical treatment may have been missed, and only systemic chemotherapy or other comprehensive treatments are available to alleviate symptoms.

Other Voices

doctor image
home-news-image
Written by Liu Wu Cai
Hepatobiliary Surgery
57sec home-news-image

Can gallbladder cancer with liver metastasis be treated?

If a gallbladder cancer patient experiences liver metastasis, aggressive treatment can be applied, but it can only be symptomatic treatment and cannot achieve a cure. Gallbladder cancer is a type of malignancy with a high degree of malignancy, prone to metastasis to other parts, and with very poor treatment outcomes. If liver metastasis occurs, the condition is severe and has reached the middle to late stages. Treatment cannot involve surgical removal at this time. Instead, active management should be employed to improve quality of life and better control the disease, though it cannot be cured. When gallbladder cancer patients experience liver metastasis, symptoms may include pain in the liver area, abnormal liver function, hypoalbuminemia, ascites, and other clinical symptoms. At this time, symptomatic treatment should be actively pursued to better maintain the patient's life and improve quality of life.

doctor image
home-news-image
Written by Liu Wu Cai
Hepatobiliary Surgery
1min 1sec home-news-image

Can gallbladder cancer be detected by cancer embryonic antigen test?

The use of cancer embryo antigen in patients with gallbladder cancer has certain reference value, but it is not absolute. Patients with gallbladder cancer typically show a significant increase in embryonic antigen. Gallbladder cancer is difficult to diagnose early as it generally does not show specific symptoms. Some patients may experience mild discomfort in the upper right abdomen, but this is often overlooked or misdiagnosed as other diseases, such as chronic gastritis. Therefore, once diagnosed with gallbladder cancer, it is usually already at a middle to late stage. Although the cancer embryo antigen in tumor marker tests of gallbladder cancer patients can be elevated, this is not absolute. Therefore, when discomfort in the upper right abdomen occurs, further comprehensive examinations like color ultrasound, CT, and other related tests are necessary to differentiate it.

doctor image
home-news-image
Written by Liu Wu Cai
Hepatobiliary Surgery
51sec home-news-image

Is targeted therapy or immunotherapy better for gallbladder cancer?

The treatment of gallbladder cancer cannot be judged as whether targeted therapy or immunotherapy is better, but should be analyzed based on the specific condition of the disease. For early-stage gallbladder cancer patients, if no metastasis has occurred, the best treatment at this time is primarily surgical removal. Early-stage surgical removal can achieve a cure, and regular postoperative ultrasound checks to monitor the disease progression are sufficient. However, if the gallbladder cancer progresses to a late stage, there might be metastasis to other parts of the body, corresponding symptoms appear, and the disease progresses rapidly. The opportunity for surgical treatment may have been missed, and only systemic chemotherapy or other comprehensive treatments are available to alleviate symptoms.

doctor image
home-news-image
Written by Liu Wu Cai
Hepatobiliary Surgery
51sec home-news-image

Is gallbladder cancer prone to spreading?

Gallbladder cancer is a type of cancer that is prone to spreading and is of a higher malignancy level. It is difficult to detect in the early stages. Patients with gallbladder cancer may initially present with subtle right upper abdominal pain, which is often overlooked. Therefore, once diagnosed with gallbladder cancer, it generally has reached the mid to late stages. At this time, the patient's pain becomes significant, which is the primary reason for seeking medical attention. Gallbladder cancer progresses rapidly and is prone to metastasize to other locations, such as the liver, leading to liver dysfunction, jaundice, ascites, hypoalbuminemia, and more. Additionally, for gallbladder cancer, the treatment strategy emphasizes early surgical removal to achieve better therapeutic outcomes.

doctor image
home-news-image
Written by Liu Wu Cai
Hepatobiliary Surgery
55sec home-news-image

Can people with gallbladder cancer eat lamb?

Patients with gallbladder cancer can appropriately eat mutton, as mutton is a food high in protein, which can supplement the albumin needed by the human body and better improve the patient's resistance. However, patients with gallbladder cancer may experience discomfort such as pain in the upper right abdomen and may also encounter digestive symptoms like indigestion and bloating. Therefore, it is recommended for gallbladder cancer patients to consume foods that are easy to digest, which can reduce the burden on the gastrointestinal tract and facilitate recovery. Although mutton can be consumed, it should be eaten in small, frequent meals to prevent complications such as intestinal obstruction. Additionally, for the treatment of gallbladder cancer, surgical removal should be used as early as possible to achieve a cure, with earlier detection and treatment likely leading to a relatively better prognosis.